Peer-reviewed journal articles featuring Fortrea oncologists published 2020-2024
Related insights
More from our insights

Detecting the Undetectable: The Rising Potential of Liquid Biopsies in Oncology
In the past decade, a vial of blood has become a powerful window into cancer biology. Liquid biopsies, once limited to detecting specific mutations in advanced lung cancer, now offer a dynamic, real-time view of tumor genetics across multiple cancer types.
Weiterlesen
Peer-reviewed journal articles featuring Fortrea oncologists published 2020-2024
Ressource herunterladen
San Francisco Bay Area biotech advances Phase I-II cancer immunotherapy trial with Fortrea
A San Francisco Bay Area biotech company approached Fortrea to manage a Phase I-II clinical trial evaluating a personalized, neoantigen-based vaccine.
Fallstudie herunterladen
Future directions in liquid biopsy technology
Recent technological advancements have dramatically improved the sensitivity of liquid biopsies, enabling earlier diagnosis, precise treatment selection and enhanced disease monitoring.
Weiterlesen
Guiding a biotech’s development of an immunotherapy cancer treatment with 'out-of-the-box' thinking
This case study delves into how Fortrea helped guide a sponsor's immunotherapy cancer treatment with out-of-the-box thinking.
Fallstudie herunterladen
Aligning core values to for a tripartite partnership and advance an oncology program
A partnership model matched the sponsor’s needs and enabled transparency in each interaction.
Fallstudie herunterladen
Our latest oncology publications
Our collaborative approach can result in co-authorship of peer-reviewed journal articles based on projects we’ve supported.
Ressource herunterladen
Beschleunigung der klinischen Entwicklung mithilfe von Studien mit einem Fokus auf Design, Diversität und Digitalisierung – in der Onkologie und in anderen Bereichen
Webinar ansehen
Clinical Development in the Precision Medicine Era
The era of precision medicine is reshaping oncology trials, offering unprecedented opportunities to tailor treatments to individual genetic profiles. This transformation brings challenges in trial design and execution, and companies must adapt their clinical development strategies to stay ahead.
Weiterlesen
It is never too early to start a strategic plan for oncology product development in the APAC region
In oncology, a goal-oriented, holistic strategic plan is crucial, even in the earliest phases of product development.
Weiterlesen
Eine wissenschaftliche Perspektive auf den Russisch-ukrainischen Krieg
Fortrea's efforts in continuing scientific research and clinical trials amidst the challenges posed by the Russia-Ukraine conflict.
WeiterlesenVerbinden Sie sich mit uns
We've been driving innovation with our tailored clinical solutions for 30+ years. Let's connect.